Clinical Trial Update: Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nadroparin calcium for the prevention of venous and arterial thromboembolism in cancer patients undergoing chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Nadroparin Calcium (nadroparin calcium)

Snippet

Sponsor: Italfarmaco | Conditions: Advanced Cancer, Metastatic Cancer | Phase 3 | Status: COMPLETED